EW Jun 2024 95.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

6.30

+0.32

(+5.35%)

At close: 12:47PM EDT

Loading interactive chart...

Simply Wall St.
Investors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
Zacks
The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.
Business Wire
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*